KLRK1 and neoplasm: NKG2D is an activating receptor expressed on the surface of different immune cells, including NK cells, which recognises ligands (NKG2DL) that are upregulated on tumour cells, resulting in NK cell-mediated recognition and cytolysis of target cells [90,91].